2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Sell
19
CRSP Quote, Financials, Valuation and Earnings
Last price:
$42.81
Seasonality move
:
6.36%
Day range:
$41.94 - $43.48
52-week range:
$36.52 - $75.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.87x
Volume:
1.4M
Avg. volume:
2.4M
1-year change:
-41.51%
Market cap:
$3.6B
Revenue:
$35M
EPS (TTM):
-$4.37
CRSP Analysts' Consensus Rating
The 24 analysts providing 12-month price projections for CRISPR Therapeutics AG shares anticipate an average target of $83.60, ranging from a low estimate of $32.00 to a high estimate of $268.00. This average target implies a growth of 98.48% compared to the current stock price of $42.12.
Consensus Price Target
$83.60
Highest Price Target
$268.00
Lowest Price Target
$32.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 10 | 11 | 12 |
| Hold | 11 | 11 | 11 |
| Sell | 2 | 2 | 1 |
| Consensus | Hold | Leans Bullish | Buy |
CRSP Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Is Goldman Sachs Stock a Buy Sell or Hold?
When the Federal Reserve started hiking rates in 2022, banks’…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
49
SMTC alert for Mar 17
Semtech [SMTC] is down 0.49% over the past day.
Buy
62
PLPC alert for Mar 17
Preformed Line Products [PLPC] is up 3.8% over the past day.
Sell
50
NUTX alert for Mar 17
Nutex Health [NUTX] is up 4.82% over the past day.
